Drug, Cosmetic & Toiletry Wholesaling in the US - Industry Market Research Report
Description
Drug, Cosmetic & Toiletry Wholesaling in the US - Industry Market Research Report
Drug, Cosmetic & Toiletry Wholesaling in the US
The success of the Drug, Cosmetic and Toiletry Wholesaling industry is driven by demand for its primary product segment, pharmaceuticals. With several major brand-name drugs losing patent exclusivity, new opportunities have been created for less expensive generic drugs on the market. Nonetheless, wholesalers have countered by adjusting their prices and supplies accordingly. As a result, industry revenue will rise a CAGR of 3.1% to $1.4 trillion over the five years to 2023. The COVID-19 pandemic has boosted demand for products as hospitalization rates skyrocketed in 2020 and 2021. In 2023 alone, industry revenue will increase 2.2%.
Drug, cosmetic and toiletry wholesalers primarily distribute pharmaceutical products intended for internal and external consumption, such as tablets, capsules, vials, ointments and powders. The industry includes a range of biological and medical products, in addition to botanical drugs and herbs. The industry does not include businesses that primarily distribute surgical, dental or hospital equipment.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
Drug, Cosmetic & Toiletry Wholesaling in the US
The success of the Drug, Cosmetic and Toiletry Wholesaling industry is driven by demand for its primary product segment, pharmaceuticals. With several major brand-name drugs losing patent exclusivity, new opportunities have been created for less expensive generic drugs on the market. Nonetheless, wholesalers have countered by adjusting their prices and supplies accordingly. As a result, industry revenue will rise a CAGR of 3.1% to $1.4 trillion over the five years to 2023. The COVID-19 pandemic has boosted demand for products as hospitalization rates skyrocketed in 2020 and 2021. In 2023 alone, industry revenue will increase 2.2%.
Drug, cosmetic and toiletry wholesalers primarily distribute pharmaceutical products intended for internal and external consumption, such as tablets, capsules, vials, ointments and powders. The industry includes a range of biological and medical products, in addition to botanical drugs and herbs. The industry does not include businesses that primarily distribute surgical, dental or hospital equipment.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
Table of Contents
48 Pages
- TABLE OF CONTENTS
ABOUT THIS INDUSTRY
Industry Definition
Main Activities
Similar Industries
Additional Resources
INDUSTRY AT A GLANCE
INDUSTRY PERFORMANCE
Executive Summary
Key External Drivers
Current Performance
Industry Outlook
Industry Life Cycle
PRODUCTS & MARKETS
Supply Chain
Products & Services
Demand Determinants
Major Markets
International Trade
Business Locations
COMPETITIVE LANDSCAPE
Market Share Concentration
Key Success Factors
Cost Structure Benchmarks
Basis of Competition
Barriers to Entry
Industry Globalization
MAJOR COMPANIES
OPERATING CONDITIONS
Capital Intensity
Technology & Systems
Revenue Volatility
Regulation & Policy
Industry Assistance
KEY STATISTICS
Industry Data
Annual Change
Key Ratios
JARGON & GLOSSARY
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
